DNASense acquired by Clinical Microbiomics πŸŽ‰

DNASense acquired by Clinical Microbiomics πŸŽ‰

DNASense acquired by Clinical Microbiomics πŸŽ‰ 1786 1644 admin

DNASense has rapidly advanced technologically and experienced significant growth in recent years. Joining Clinical Microbiomics, a leading microbiome CRO in North America and Europe, marks another major milestone in our development, furthering our mission to enable pioneering microbiome science across a wide array of human, animal, and environmental applications.

Benefiting from the challenging projects received from customers and collaborators, DNASense has thrived as a cutting-edge startup. As part of Clinical Microbiomics, we aim to enhance our services for all stakeholders further. 🌟

Also, looking even further ahead, we are thrilled to announce unveiling a new parent company brand in the summer of 2024, reflecting the shared vision of Clinical Microbiomics and DNASense and advancing the microbiome revolution. 🧬🦠

Read more at: clinical-microbiomics.com/dnasense/

    Company / Institution

    Inquiry

      Company / Institution

      Inquiry

      DNASense is now a part of Clinical Microbiomics.

      X